Skip to content ↓

Topic

Koch Institute

Download RSS feed: News Articles / In the Media / Audio

Displaying 46 - 60 of 273 news clips related to this topic.
Show:

Boston.com

Boston.com reporter Madeleine Aitken writes that MIT researchers have created a new blood test that can measure immune protection against Covid-19. The new test measures the “level of neutralizing antibodies in a blood sample, using the same type of ‘lateral flow’ technology as antigen tests,” writes Aitken.

Boston Herald

Boston Herald reporter Rick Sobey writes that MIT researchers have developed a blood test that can predict Covid-19 immunity. “The MIT researchers created a paper test that measures the level of neutralizing antibodies in a blood sample, which could help people decide what protections they should take against infection,” writes Sobey. “Their test uses the same type of 'lateral flow' technology as most rapid antigen tests for Covid.”

Forbes

Forbes contributor Russell Flannery spotlights how Prof. Tyler Jacks has “made a mark in cancer work not only by his research but his ability to bring different organizations together.” Jacks discussed the Biden administration’s “Cancer Moonshot” initiative and noted that: “Having specific goals and an action plan for cancer is important. Having a strategy about how to approach the cancer problem is equally important.”

Newsweek

Scientists at MIT are developing a self-boosting vaccine that can provide multiple doses of a vaccine via a single injection, reports Darko Manevski for Newsweek. The technology “could be particularly useful for administering childhood vaccinations in regions where people do not have regular access to medical care,” writes Manevski.

The Economist

MIT scientists are developing self-boosting vaccine technology that could allow people to receive all of their vaccine doses in one shot, reports The Economist. This technology “would be a game-changer, not only for future pandemics but also for vaccination programs in remote regions where it is harder to deliver boosters,” The Economist notes.

The Boston Globe

The Boston Globe highlights Robert Buderi’s new book, “Where Futures Converge: Kendall Square and the Making of a Global Innovation Hub.” Buderi features the Future Founders Initiative, an effort by Prof. Sangeeta Bhatia, President Emerita Susan Hockfield and Prof. Emerita Nancy Hopkins aimed at increasing female entrepreneurship. 

STAT

STAT has named Noubar Afeyan ’87, Cornelia Bargmann PhD ’87, Prof. Regina Barzilay and Prof. Sangeeta N. Bhatia to their list of trailblazing researchers working in the life sciences. “Many of the STATUS List are well-known as change makers; others are largely unheralded heroes. But all have compelling stories to tell,” writes STAT.

Forbes

David Lucchino ’06 and Prof. Robert Langer have co-founded Frequency Therapeutics, a biotechnology company focused on developing a new approach to restoring hearing from the most common form of hearing loss, reports Jack Kelly for Forbes. “FX-322 is designed to treat the underlying cause of SNHL (sensorineural hearing loss) by regenerating sensory hair cells through activation of progenitor cells already present in the cochlea,” writes Kelly.

Newsweek

Researchers from MIT and the La Jolla Institute for Immunology have found a vaccine ingredient that may strengthen immune response, reports Natalie Colarossi for Newsweek. This combination-style vaccine ingredient “may boost the effectiveness of inoculations ranging from HIV to Covid-19,” writes Colarossi.

Forbes

Forbes reporter Jack Kelly profiles Institute Prof. Robert Langer, spotlighting his career journey and his passion for helping others. “I traded job security and high pay for doing things I was passionate about,” Langer explains. “Out of over 20 job offers I received upon graduation from college, I chose the lowest paying one by far because I thought by doing so, I could potentially improve the health of patients. I dreamed about doing things that I thought would make the world a better place.”

NIH

Writing for the NIH Director’s Blog, Dr. Francis Collins highlights how Prof. Tyler Jacks and research scientist Megan Burger’s work exploring T cell exhaustion led to the creation of a “strategy for developing cancer vaccines that can ‘awaken’ T cells and reinvigorate the body’s natural cancer-fighting abilities.” Collins writes that “the researchers hope to learn if this approach to cancer vaccines might work even better when used in combination with immunotherapy drugs, which unleash the immune system against cancer in other ways.”

The Boston Globe

Boston Globe reporter Steve Annear spotlights research specialist Kathy Cormier’s dedication to tending a flower planter at the Collier Memorial. “Here’s something that’s empty that I can fill, and make myself feel better and make other people — hopefully — feel better,” says Cormier. MIT Chief of Police John DiFava says, “what she is doing is just so amazing. I just think it’s wonderful and it’s so illustrative of the way we have been treated here.”

Bloomberg Businessweek

Orna Therapeutics, which was co-founded by MIT researchers, is working on “programming RNA with genetic code that instructs a line to split into several strands and then repair itself in the shape of a circle,” reports Bloomberg Businessweek reporter Angelica LaVito. “Delivering those messages via circles may produce a more stable, longer-lasting signal, potentially treating cancer, autoimmune disorders, and genetic diseases.”

Inside Higher Ed

Institute Professor Paula Hammond, head of MIT’s Department of Chemical Engineering, has been selected to serve on the President's Council of Advisors on Science and Technology, “a group of external advisers tasked with making science, technology and innovation policy recommendations to the White House and the president,” reports Alexis Gravely for Inside Higher Ed. Professors Maria Zuber, MIT vice president for research, and Eric Lander, the president’s science adviser and director of the White House Office of Science and Technology Policy, are two of the co-chairs for the council.

The Wall Street Journal

In an article for The Wall Street Journal about efforts to help repair or prevent cartilage damage before osteoarthritis sets in, Laura Landro spotlights how MIT researchers are developing “ways to get drugs into the cartilage tissue and keep them there. They are using microscopic particles called nanocarriers to deliver IGF-1, an insulin like growth factor, to the tight mesh that holds cartilage in joints.”